Back to top
more

NantHealth, Inc. (NH)

(Delayed Data from NSDQ)

$0.68 USD

0.68
71,216

-0.01 (-0.74%)

Updated May 3, 2019 04:00 PM ET

After-Market: $0.67 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

NantHealth, Inc. (NH) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

NantHealth, Inc. (NH) delivered earnings and revenue surprises of -11.11% and 0.19%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: NantHealth, Inc. (NH) Q4 Earnings Expected to Decline

by Zacks Equity Research

NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Outset Medical, Inc. (OM) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Outset Medical, Inc. (OM) delivered earnings and revenue surprises of -14.93% and 6.04%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

NantHealth, Inc. (NH) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

NantHealth, Inc. (NH) delivered earnings and revenue surprises of -25.00% and -18.88%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: NantHealth, Inc. (NH) Q3 Earnings Expected to Decline

by Zacks Equity Research

NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NantHealth, Inc. (NH) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

NantHealth, Inc. (NH) delivered earnings and revenue surprises of 20.00% and -5.35%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate NantHealth, Inc. (NH) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Industry Outlook Highlights: Omnicell, NextGen Healthcare, NantHealth, Allscripts Healthcare Solutions and Quest Diagnostics

by Zacks Equity Research

Zacks Industry Outlook Highlights: Omnicell, NextGen Healthcare, NantHealth, Allscripts Healthcare Solutions and Quest Diagnostics

Urmimala Biswas headshot

3 Top Medical Info Systems Stocks to Beat COVID-19 Resurgence Crisis

by Urmimala Biswas

Despite the severe challenges posed by the COVID-19 pandemic, higher demand for telemedicine, digital influence and AI is likely to lend support to the Zacks Medical - Information industry. OMCL, NXGN and NH are well positioned to gain.

Implied Volatility Surging for NantHealth (NH) Stock Options

by Zacks Equity Research

Investors need to pay close attention to NantHealth (NH) stock based on the movements in the options market lately.

NantHealth, Inc. (NH) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

NantHealth, Inc. (NH) delivered earnings and revenue surprises of -16.67% and -3.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

NantHealth (NH) Looks Good: Stock Adds 9.1% in Session

by Zacks Equity Research

NantHealth (NH) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

NantHealth Inc (NH) Reports Q1 Loss, Lags Revenue Estimates

by Zacks Equity Research

NantHealth Inc (NH) delivered earnings and revenue surprises of 14.29% and -5.80%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

NantHealth, Inc. (NH) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

NantHealth, Inc. (NH) delivered earnings and revenue surprises of -75.00% and -4.46%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

NantHealth, Inc. (NH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NantHealth, Inc. (NH) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

NantHealth, Inc. (NH) delivered earnings and revenue surprises of 55.56% and 7.03%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

NantHealth, Inc. (NH) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

by Zacks Equity Research

NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Invitae (NVTA) Catches Eye: Stock Jumps 9.1%

by Zacks Equity Research

Invitae (NVTA) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

NantHealth, Inc. (NH) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

NantHealth, Inc. (NH) delivered earnings and revenue surprises of 23.08% and -10.83%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Will NantHealth, Inc. (NH) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

NantHealth, Inc. (NH) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

NantHealth, Inc. (NH) delivered earnings and revenue surprises of -11.11% and -10.01%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

    NantHealth (NH) Shares March Higher, Can It Continue?

    by Zacks Equity Research

    NantHealth Inc (NH) has been on the move lately as the stock has risen by 5.7% in the past four weeks, and it is currently trading well above its 20-Day SMA

      What Makes NantHealth (NH) a Strong Sell?

      by Zacks Equity Research

      NantHealth (NH), has witnessed a significant price decline and negative trend in earnings estimate revisions